DrugNov 21, 2018
ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial recall — FDA D-0248-2019
Labeling: Missing label; potential for missing primary container label on the vial.
Class IIIFDA: TerminatedEli Lilly & Co
Recall history in this database
Classification mix: Class III: 1.
Understanding this recall history
This page summarizes recall records in which the official source identifies Eli Lilly & Co as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.